Risk that regulatory violations, medical malpractice or unexpected treatment outcomes at other medical institutions and similar organisations damage the reputation of, and reduce confidence in, the regenerative medicine industry as a whole. This concerns reputational spillover from events involving other companies or institutions in the industry, rather than quality issues with the company's products or accidents involving its services.